Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 51 results.
User Information
Export Records
  1. 1.   Energetic and structural features of SARS-CoV-2 N-protein co-assemblies with nucleic acids
  2. Zhao, Huaying; Nguyen, Ai; Li, Yan; Adao, Regina C.; Valkov,Eugene; Patterson, George H.; Piszczek, Grzegorz; Schuck, Peter
  3. iScience. 2021, Jun 25; 24(6):
  1. 2.   Involvement of the N Domain Residues E34, K35, and R38 in the Functionally Active Structure of Escherichia coli Lon Protease
  2. Andrianova, A. G.; Kudzhaev, A. M.; Abrikosova, V. A.; Gustchina,Alla; Smirnov, I. V.; Rotanova, T. V.
  3. Acta Naturae. 2020, Oct-Dec; 12(4): 86-97.
  1. 3.   FLCN: The causative gene for Birt-Hogg-Dube syndrome
  2. Schmidt, Laura; Linehan, W. Marston
  3. GENE. 2018, Jan 15; 640: 28-42.
  1. 4.   Structural analyses of the Haemophilus influenzae peptidoglycan synthase activator LpoA suggest multiple conformations in solution
  2. Sathiyamoorthy, Karthik; Vijayalakshmi, J; Tirupati, Bhramara; Fan, Lixin; Saper, Mark A
  3. The Journal of Biological Chemistry. 2017, Oct 27; 292(43): 17626-17642.
  1. 5.   Solution Properties of Murine Leukemia Virus Gag Protein: Differences from HIV-1 Gag
  2. Datta, S. A. K.; Zuo, X. B.; Clark, P. K.; Campbell, S. J.; Wang, Y. X.; Rein, A.
  3. Journal of Virology. 2011, Dec; 85(23): 12733-12741.
  1. 6.   The effects of RNase H inhibitors and nevirapine on the susceptibility of HIV-1 to AZT and 3TC
  2. Davis, C. A.; Parniak, M. A.; Hughes, S. H.
  3. Virology. 2011, Oct; 419(2): 64-71.
  1. 7.   Symmetry-Based Self-assembled Nanotubes Constructed Using Native Protein Structures: The Key Role of Flexible Linkers
  2. Buch, I.; Tsai, C. J.; Wolfson, H. J.; Nussinov, R.
  3. Protein and Peptide Letters. 2011, Apr; 18(4): 362-372.
  1. 8.   Topology of the disulfide bonds in the antiviral lectin scytovirin
  2. Moulaei, T.; Stuchlik, O.; Reed, M.; Yuan, W. R.; Pohl, J.; Lu, W. Y.; Haugh-Krumpe, L.; O'Keefe, B. R.; Wlodawer, A.
  3. Protein Science. 2010, Sep; 19(9): 1649-1661.
  1. 9.   Limitations of Peptide Retro-inverso Isomerization in Molecular Mimicry
  2. Li, C.; Pazgier, M.; Li, J.; Li, C. Q.; Liu, M.; Zou, G. Z.; Li, Z. Y.; Chen, J. D.; Tarasov, S. G.; Lu, W. Y.
  3. Journal of Biological Chemistry. 2010, Jun; 285(25): 19572-19581.
  1. 10.   A Novel Molecular Mechanism of Dual Resistance to Nucleoside and Nonnucleoside Reverse Transcriptase Inhibitors
  2. Nikolenko, G. N.; Delviks-Frankenberry, K. A.; Pathak, V. K.
  3. Journal of Virology. 2010, May; 84(10): 5238-5249.
  1. 11.   A large human domain antibody library combining heavy and light chain CDR3 diversity
  2. Chen, W. Z.; Zhu, Z. Y.; Feng, Y.; Dimitrov, D. S.
  3. Molecular Immunology. 2010, Jan; 47(4): 912-921.
  1. 12.   Structure of the Taz2 domain of p300: insights into ligand binding
  2. Miller, M.; Dauter, Z.; Cherry, S.; Tropea, J. E.; Wlodawer, A.
  3. Acta crystallographica. Section D, Biological crystallography. 2009, Dec; 65(Pt 12): 1301-8.
  1. 13.   Signaling dynamics of the KSR1 scaffold complex
  2. McKay, M. M.; Ritt, D. A.; Morrison, D. K.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2009, Jul 7; 106(27): 11022-7.
  1. 14.   Structural Basis for p300 Taz2-p53 TAD1 Binding and Modulation by Phosphorylation
  2. Feng, H. Q.; Jenkins, L.; Durell, S. R.; Hayashi, R.; Mazur, S. J.; Cherry, S.; Tropea, J. E.; Miller, M.; Wlodawer, A.; Appella, E.; Bai, Y.
  3. Structure. 2009 17(2): 202-210.
  1. 15.   Two Distinct Motifs within the p53 Transactivation Domain Bind to the Taz2 Domain of p300 and Are Differentially Affected by Phosphorylation
  2. Jenkins, L.; Yamaguchi, H.; Hayashi, R.; Cherry, S.; Tropea, J. E.; Miller, M.; Wlodawer, A.; Appella, E.; Mazur, S. J.
  3. Biochemistry. 2009 48(6): 1244-1255.
  1. 16.   Computer Simulations of Peptides from the p53 DNA Binding Domain
  2. Khalili, M.; Wales, D. J.
  3. Journal of Chemical Theory and Computation. 2009 5(5): 1380-1392.
  1. 17.   Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX
  2. Pazgiera, M.; Liu, M.; Zou, G. Z.; Yuan, W. R.; Li, C. Q.; Li, C.; Li, J.; Monbo, J.; Zella, D.; Tarasov, S. G.; Lu, W.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2009 106(12): 4665-4670.
  1. 18.   Towards inferring time dimensionality in protein-protein interaction networks by integrating structures: the p53 example
  2. Tuncbag, N.; Kar, G.; Gursoy, A.; Keskin, O.; Nussinov, R.
  3. Molecular Biosystems. 2009 5(12): 1770-1778.
  1. 19.   Discoidin domain receptor 1 mediates collagen-induced nitric oxide production in J774A.1 murine macrophages
  2. Kim, S. H.; Lee, S.; Suk, K.; Bark, H.; Jun, C. D.; Kim, D. K.; Choi, C. H.; Yoshimura, T.
  3. Free Radical Biology and Medicine. 2007, Feb; 42(3): 343-352.
  1. 20.   Interactions between HIV-1 Gag molecules in solution: An inositol phosphate-mediated switch
  2. Datta, S. A. K.; Zhao, Z.; Clark, P. K.; Tarasov, S.; Alexandratos, J. N.; Campbell, S. J.; Kvaratskhelia, M.; Lebowitz, J.; Rein, A.
  3. Journal of Molecular Biology. 2007, Jan; 365(3): 799-811.
  1. 21.   Conformation of the HIV-1 Gag protein in solution
  2. Datta, S. A. K.; Curtis, J. E.; Ratcliff, W.; Clark, P. K.; Crist, R. M.; Lebowitz, J.; Krueger, S.; Rein, A.
  3. Journal of Molecular Biology. 2007, Jan; 365(3): 812-824.
  1. 22.   In vitro resistance to the human immunodeficiency virus type 1 maturation inhibitor PA-457 (Bevirimat)
  2. Adamson, C. S.; Ablan, S. D.; Boeras, I.; Goila-Gaur, R.; Soheilian, F.; Nagashima, K.; Li, F.; Salzwedel, K.; Sakalian, M.; Wild, C. T.; Freed, E. O.
  3. Journal of Virology. 2006, Nov; 80(22): 10957-10971.
  1. 25.   A threshold requirement for Gbx2 levels in hindbrain development
  2. Waters, S. T.; Lewandoski, M.
  3. Development. 2006, May; 133(10): 1991-2000.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel